Folgen
Magda Tsolaki
Magda Tsolaki
AlzheimerHellas
Bestätigte E-Mail-Adresse bei med.auth.gr - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nature genetics 45 (12), 1452-1458, 2013
34632013
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ...
Nature genetics 41 (10), 1088-1093, 2009
29342009
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature genetics 43 (5), 429-435, 2011
18702011
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
Jama 302 (4), 385-393, 2009
12972009
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
12222019
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
11502015
Analysis of shared heritability in common disorders of the brain
Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ...
Science 360 (6395), eaap8757, 2018
9882018
Rivastigmine for Alzheimer's disease
JS Birks, JG Evans
Cochrane Database of systematic reviews, 2015
9442015
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
6662017
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA …
PJ Visser, F Verhey, DL Knol, P Scheltens, LO Wahlund, Y Freund-Levi, ...
The Lancet Neurology 8 (7), 619-627, 2009
6552009
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
M Emre, M Tsolaki, U Bonuccelli, A Destée, E Tolosa, A Kutzelnigg, ...
The Lancet Neurology 9 (10), 969-977, 2010
4742010
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
K Jekel, M Damian, C Wattmo, L Hausner, R Bullock, PJ Connelly, ...
Alzheimer's research & therapy 7 (1), 1-20, 2015
4542015
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease
M Thambisetty, A Simmons, L Velayudhan, A Hye, J Campbell, Y Zhang, ...
Archives of general psychiatry 67 (7), 739-748, 2010
4462010
Neuropsychiatric syndromes in dementia
P Aalten, FRJ Verhey, M Boziki, R Bullock, EJ Byrne, V Camus, M Caputo, ...
Dementia and geriatric cognitive disorders 24 (6), 457-463, 2007
4242007
The validation of the short form of the Geriatric Depression Scale (GDS) in Greece
KN Fountoulakis, M Tsolaki, A Iacovides, J Yesavage, R O’hara, A Kazis, ...
Aging Clinical and Experimental Research 11 (6), 367-372, 1999
3421999
Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study
E Castro-Costa, M Dewey, R Stewart, S Banerjee, F Huppert, ...
The British journal of psychiatry 191 (5), 393-401, 2007
3242007
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ...
Brain 138 (5), 1327-1338, 2015
3022015
European Alzheimer’s Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer’s Disease; Alzheimer’s Disease Genetic Consortium; Cohorts for Heart and Aging …
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nat Genet 45 (12), 1452-1458, 2013
2732013
The cerebrospinal fluid “Alzheimer profile”: easily said, but what does it mean?
FH Duits, CE Teunissen, FH Bouwman, PJ Visser, N Mattsson, ...
Alzheimer's & Dementia 10 (6), 713-723. e2, 2014
2692014
Mini mental state examination (MMSE): a validation study in Greece
KN Fountoulakis, M Tsolaki, H Chantzi, A Kazis
American Journal of Alzheimer's Disease & Other Dementias® 15 (6), 342-345, 2000
2662000
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20